{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T09:03:12Z","timestamp":1771232592707,"version":"3.50.1"},"reference-count":150,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1016\/j.tripleo.2006.11.004","type":"journal-article","created":{"date-parts":[[2007,3,21]],"date-time":"2007-03-21T10:52:47Z","timestamp":1174474367000},"page":"S12.e1-S12.e18","source":"Crossref","is-referenced-by-count":36,"special_numbering":"S","title":["Management of recurrent oral herpes simplex infections"],"prefix":"10.1016","volume":"103","author":[{"given":"Sook-Bin","family":"Woo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen J.","family":"Challacombe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tripleo.2006.11.004_bib1","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1056\/NEJM199911043411904","article-title":"A prospective study of new infections with herpes simplex virus type 1 and type 2","volume":"341","author":"Langenberg","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tripleo.2006.11.004_bib2","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1086\/340041","article-title":"Seroprevalence and coinfection with herpes simplex virus type 1 and type 2 in the United States, 1988-1994","volume":"185","author":"Xu","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tripleo.2006.11.004_bib3","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1177\/10454411980090040901","article-title":"Molecular aspects of herpes simplex virus I latency, reactivation, and recurrence","volume":"9","author":"Miller","year":"1998","journal-title":"Crit Rev Oral Biol Med"},{"key":"10.1016\/j.tripleo.2006.11.004_bib4","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/jmv.1890460116","article-title":"Herpes simplex virus DNA in normal corneas: persistence without viral shedding from ganglia","volume":"46","author":"Openshaw","year":"1995","journal-title":"J Med Virol"},{"key":"10.1016\/j.tripleo.2006.11.004_bib5","doi-asserted-by":"crossref","first-page":"6524","DOI":"10.1128\/JVI.70.9.6524-6528.1996","article-title":"In vitro establishment of lytic and nonproductive infection by herpes simplex virus type 1 in three-dimensional keratinocyte culture","volume":"70","author":"Syrjanen","year":"1996","journal-title":"J Virol"},{"key":"10.1016\/j.tripleo.2006.11.004_bib6","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1086\/313647","article-title":"Herpes simplex virus type 2 shedding in human immunodeficiency virus-negative men who have sex with men: frequency, patterns, and risk factors","volume":"30","author":"Krone","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tripleo.2006.11.004_bib7","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1128\/JCM.43.5.2173-2180.2005","article-title":"Effect of prophylactic valacyclovir on the presence of human herpesvirus DNA in saliva of healthy individuals after dental treatment","volume":"43","author":"Miller","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.tripleo.2006.11.004_bib8","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1034\/j.1399-302x.2000.150502.x","article-title":"Subclinical reactivation of herpes simplex virus type 1 in the oral cavity","volume":"15","author":"Knaup","year":"2000","journal-title":"Oral Microbiol Immunol"},{"key":"10.1016\/j.tripleo.2006.11.004_bib9","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1167\/iovs.04-0614","article-title":"HSV-1 DNA in tears and saliva of normal adults","volume":"46","author":"Kaufman","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.tripleo.2006.11.004_bib10","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1086\/379043","article-title":"Polymerase chain reaction for detection of herpes simplex virus (HSV) DNA on mucosal surfaces: comparison with HSV isolation in cell culture","volume":"188","author":"Wald","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tripleo.2006.11.004_bib11","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1056\/NEJM198706043162304","article-title":"Recurrences after oral and genital herpes simplex virus infection","volume":"316","author":"Lafferty","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tripleo.2006.11.004_bib12","doi-asserted-by":"crossref","first-page":"5343","DOI":"10.1128\/JVI.72.7.5343-5350.1998","article-title":"The latent herpes simplex virus type 1 genome copy number in individual neurons is virus strain specific and correlates with reactivation","volume":"72","author":"Sawtell","year":"1998","journal-title":"J Virol"},{"key":"10.1016\/j.tripleo.2006.11.004_bib13","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1136\/sti.2003.007823","article-title":"Oral shedding of herpes simplex virus type 2","volume":"80","author":"Wald","year":"2004","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.tripleo.2006.11.004_bib14","doi-asserted-by":"crossref","first-page":"4380","DOI":"10.4049\/jimmunol.170.8.4380","article-title":"T cell immunity to herpes simplex viruses in seronegative subjects: silent infection or acquired immunity?","volume":"170","author":"Posavad","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.tripleo.2006.11.004_bib15","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1177\/154405910208100612","article-title":"Salivary defense factors in herpes simplex virus infection","volume":"81","author":"Valimaa","year":"2002","journal-title":"J Dent Res"},{"key":"10.1016\/j.tripleo.2006.11.004_bib16","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1086\/313687","article-title":"Prospects for control of herpes simplex virus disease through immunization","volume":"30","author":"Stanberry","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tripleo.2006.11.004_bib17","doi-asserted-by":"crossref","first-page":"81","DOI":"10.14219\/jada.archive.1970.0157","article-title":"Intraoral ulcerations of recurrent herpes simplex and recurrent aphthae: two distinct clinical entities","volume":"81","author":"Weathers","year":"1970","journal-title":"J Am Dent Assoc"},{"key":"10.1016\/j.tripleo.2006.11.004_bib18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.7326\/0003-4819-124-1_Part_1-199601010-00005","article-title":"Bell palsy and herpes simplex virus: identification of viral DNA in endoneurial fluid and muscle","volume":"124","author":"Murakami","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.tripleo.2006.11.004_bib19","doi-asserted-by":"crossref","first-page":"63","DOI":"10.7326\/0003-4819-124-1_Part_1-199601010-00010","article-title":"Herpes simplex virus and Bell palsy","volume":"124","author":"Baringer","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.tripleo.2006.11.004_bib20","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/(SICI)1096-9071(199803)54:3<162::AID-JMV3>3.0.CO;2-3","article-title":"Reactivation of herpes simplex virus type 1 in patients with Bell\u2019s palsy","volume":"54","author":"Furuta","year":"1998","journal-title":"J Med Virol"},{"key":"10.1016\/j.tripleo.2006.11.004_bib21","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1177\/000348949610500508","article-title":"Bell\u2019s palsy treatment with acyclovir and prednisone compared with prednisone alone: a double-blind, randomized, controlled trial","volume":"105","author":"Adour","year":"1996","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.tripleo.2006.11.004_bib22","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1177\/000348940311200301","article-title":"Outcome of treatment with valacyclovir and prednisone in patients with Bell\u2019s palsy","volume":"112","author":"Axelsson","year":"2003","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.tripleo.2006.11.004_bib23","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/jmv.10502","article-title":"Detection and genotyping of human herpes simplex viruses in cutaneous lesions of erythema multiforme by nested PCR","volume":"71","author":"Sun","year":"2003","journal-title":"J Med Virol"},{"key":"10.1016\/j.tripleo.2006.11.004_bib24","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1046\/j.1523-1747.1999.00754.x","article-title":"Herpes simplex virus associated erythema multiforme (HAEM) is mechanistically distinct from drug-induced erythema multiforme: interferon-gamma is expressed in HAEM lesions and tumor necrosis factor-alpha in drug-induced erythema multiforme lesions","volume":"113","author":"Kokuba","year":"1999","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.tripleo.2006.11.004_bib25","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0278-2391(10)80347-7","article-title":"Reactivated herpes simplex virus infection as a possible cause of dry socket after tooth extraction","volume":"51","author":"Hedner","year":"1993","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.tripleo.2006.11.004_bib26","first-page":"627","article-title":"Prevalence of recurrent herpes labialis and aphthous ulcers among young adults on six continents","volume":"113","author":"Embil","year":"1975","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.tripleo.2006.11.004_bib27","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/0030-4220(76)90277-2","article-title":"A clinical study for the control of facial mucocutaneous herpes virus infections","volume":"41","author":"Young","year":"1976","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1016\/j.tripleo.2006.11.004_bib28","doi-asserted-by":"crossref","first-page":"645","DOI":"10.14219\/jada.archive.1967.0276","article-title":"The patient with recurrent aphthous ulcers and the patient with recurrent herpes labialis: a study of two population samples","volume":"75","author":"Ship","year":"1967","journal-title":"J Am Dent Assoc"},{"key":"10.1016\/j.tripleo.2006.11.004_bib29","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1056\/NEJM197707142970201","article-title":"The natural history of recurrent herpes simplex labialis: implications for antiviral therapy","volume":"297","author":"Spruance","year":"1977","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tripleo.2006.11.004_bib30","first-page":"498","article-title":"Recurrent herpes simplex labialis: selected therapeutic options","volume":"69","author":"Raborn","year":"2003","journal-title":"J Can Dent Assoc"},{"key":"10.1016\/j.tripleo.2006.11.004_bib31","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/bmj.312.7022.6","article-title":"Acyclovir in recurrent herpes labialis","volume":"312","author":"Worrall","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.tripleo.2006.11.004_bib32","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1749-6632.1970.tb53392.x","article-title":"Topical idoxuridine in recurrent herpes simplex","volume":"173","author":"Kibrick","year":"1970","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.tripleo.2006.11.004_bib33","doi-asserted-by":"crossref","first-page":"479","DOI":"10.5694\/j.1326-5377.1975.tb111504.x","article-title":"Topical treatment of recurrent herpes simplex with cytosine arabinoside","volume":"01","author":"Marks","year":"1975","journal-title":"Med J Aust"},{"key":"10.1016\/j.tripleo.2006.11.004_bib34","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1056\/NEJM197511062931901","article-title":"Failure of neutral-red photodynamic inactivation in recurrent herpes simplex virus infections","volume":"293","author":"Myers","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tripleo.2006.11.004_bib35","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1001\/archderm.113.11.1550","article-title":"Topical treatment of herpes labialis with chloroform","volume":"113","author":"Taylor","year":"1977","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.tripleo.2006.11.004_bib36","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/jama.243.10.1059","article-title":"Topical ether and herpes simplex labialis","volume":"243","author":"Guinan","year":"1980","journal-title":"JAMA"},{"key":"10.1016\/j.tripleo.2006.11.004_bib37","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2340\/00015555608587","article-title":"Lysine prophylaxis in recurrent herpes simplex labialis: a double-blind, controlled crossover study","volume":"60","author":"Milman","year":"1980","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.tripleo.2006.11.004_bib38","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/0030-4220(84)90030-6","article-title":"Lysine as a prophylactic agent in the treatment of recurrent herpes simplex labialis","volume":"58","author":"Thein","year":"1984","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1016\/j.tripleo.2006.11.004_bib39","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/0030-4220(79)90169-5","article-title":"A clinical trial of topically applied 3 percent vidarabine against recurrent herpes labialis","volume":"47","author":"Rowe","year":"1979","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1016\/j.tripleo.2006.11.004_bib40","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1093\/infdis\/154.6.930","article-title":"Iontophoresis of vidarabine monophosphate for herpes orolabialis","volume":"154","author":"Gangarosa","year":"1986","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tripleo.2006.11.004_bib41","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1128\/AAC.15.5.662","article-title":"Treatment of recurrent herpes simplex labialis with levamisole","volume":"15","author":"Spruance","year":"1979","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tripleo.2006.11.004_bib42","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/infdis\/137.5.597","article-title":"A double-blind, controlled trial of levamisole in the treatment of recurrent herpes labialis","volume":"137","author":"Russell","year":"1978","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tripleo.2006.11.004_bib43","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/infdis\/161.2.185","article-title":"Treatment of recurrent herpes simplex labialis with oral acyclovir","volume":"161","author":"Spruance","year":"1990","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tripleo.2006.11.004_bib44","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1056\/NEJM199904223401608","article-title":"Antiviral drugs","volume":"340","author":"Balfour","year":"1999","journal-title":"N Engl J Med"},{"issue":"Suppl B","key":"10.1016\/j.tripleo.2006.11.004_bib45","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/jac\/12.suppl_B.29","article-title":"Pharmacokinetics of acyclovir after intravenous and oral administration","volume":"12","author":"de Miranda","year":"1983","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.tripleo.2006.11.004_bib46","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/infdis\/146.1.85","article-title":"Treatment of herpes simplex labialis with topical acyclovir in polyethylene glycol","volume":"146","author":"Spruance","year":"1982","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tripleo.2006.11.004_bib47","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1365-2133.1983.tb03548.x","article-title":"Topical acyclovir in the management of recurrent herpes labialis","volume":"109","author":"Fiddian","year":"1983","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.tripleo.2006.11.004_bib48","first-page":"39","article-title":"Treatment of herpes labialis with acyclovir","volume":"85","author":"Raborn","year":"1988","journal-title":"Am J Med"},{"key":"10.1016\/j.tripleo.2006.11.004_bib49","first-page":"135","article-title":"Herpes labialis treatment with acyclovir 5 per cent ointment","volume":"55","author":"Raborn","year":"1989","journal-title":"J Can Dent Assoc"},{"issue":"Suppl B","key":"10.1016\/j.tripleo.2006.11.004_bib50","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/jac\/12.suppl_B.89","article-title":"Topical acyclovir therapy in patients with recurrent orofacial herpes simplex infections","volume":"12","author":"Van Vloten","year":"1983","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.tripleo.2006.11.004_bib51","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1136\/bmj.286.6379.1699","article-title":"Successful treatment of herpes labialis with topical acyclovir","volume":"286","author":"Fiddian","year":"1983","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.tripleo.2006.11.004_bib52","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1128\/AAC.46.7.2238-2243.2002","article-title":"Acyclovir cream for treatment of herpes simplex labialis: results of two randomized, double-blind, vehicle-controlled, multicenter clinical trials","volume":"46","author":"Spruance","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tripleo.2006.11.004_bib53","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1159\/000249307","article-title":"Prophylaxis against herpes labialis with acyclovir cream\u2014a placebo-controlled study","volume":"172","author":"Gibson","year":"1986","journal-title":"Dermatologica"},{"key":"10.1016\/j.tripleo.2006.11.004_bib54","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1136\/bmj.291.6487.7","article-title":"Failure of acyclovir cream in treatment of recurrent herpes labialis","volume":"291","author":"Shaw","year":"1985","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.tripleo.2006.11.004_bib55","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/0030-4220(89)90007-8","article-title":"Herpes labialis treatment with acyclovir 5% modified aqueous cream: a double-blind randomized trial","volume":"67","author":"Raborn","year":"1989","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1016\/j.tripleo.2006.11.004_bib56","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0011-393X(96)80032-4","article-title":"Efficacy of 86C (acyclovir) cream 5% compared with Zovirax (acyclovir) cream 5% in the treatment of recurrent herpes labialis","volume":"57","author":"Ottevanger","year":"1996","journal-title":"Curr Therap Res"},{"key":"10.1016\/j.tripleo.2006.11.004_bib57","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/S1079-2104(99)70164-2","article-title":"A clinical evaluation of a novel liposomal carrier for acyclovir in the topical treatment of recurrent herpes labialis","volume":"87","author":"Horwitz","year":"1999","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.tripleo.2006.11.004_bib58","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1128\/AAC.46.6.1870-1874.2002","article-title":"Double-blind, randomized, placebo-controlled study of topical 5% acyclovir-1% hydrocortisone cream (ME-609) for treatment of UV radiation-induced herpes labialis","volume":"46","author":"Evans","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tripleo.2006.11.004_bib59","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1128\/AAC.25.5.553","article-title":"Early, patient-initiated treatment of herpes labialis with topical 10% acyclovir","volume":"25","author":"Spruance","year":"1984","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tripleo.2006.11.004_bib60","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1128\/AAC.29.5.730","article-title":"Failure of topical acyclovir in ointment to penetrate human skin","volume":"29","author":"Freeman","year":"1986","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tripleo.2006.11.004_bib61","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ijpharm.2005.07.020","article-title":"Are all aciclovir cream formulations bioequivalent?","volume":"304","author":"Trottet","year":"2005","journal-title":"Int J Pharm"},{"key":"10.1016\/j.tripleo.2006.11.004_bib62","doi-asserted-by":"crossref","first-page":"38","DOI":"10.14219\/jada.archive.1987.0211","article-title":"Oral acyclovir and herpes labialis: a randomized, double-blind, placebo-controlled study","volume":"115","author":"Raborn","year":"1987","journal-title":"J Am Dent Assoc"},{"key":"10.1016\/j.tripleo.2006.11.004_bib63","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/0003-4819-118-4-199302150-00004","article-title":"Oral acyclovir to suppress frequently recurrent herpes labialis","volume":"118","author":"Rooney","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.tripleo.2006.11.004_bib64","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1001\/jama.260.11.1597","article-title":"Acyclovir prevents reactivation of herpes simplex labialis in skiers","volume":"260","author":"Spruance","year":"1988","journal-title":"JAMA"},{"key":"10.1016\/j.tripleo.2006.11.004_bib65","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1093\/infdis\/163.4.728","article-title":"The natural history of ultraviolet radiation-induced herpes simplex labialis and response to therapy with peroral and topical formulations of acyclovir","volume":"163","author":"Spruance","year":"1991","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tripleo.2006.11.004_bib66","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3109\/09546639809160682","article-title":"Assessment of the effect of a sunblock stick in the prevention of solar-stimulating ultraviolet light-induced herpes labialis","volume":"9","author":"Duteil","year":"1998","journal-title":"J Dermatologic Treat"},{"key":"10.1016\/j.tripleo.2006.11.004_bib67","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/0140-6736(91)92723-F","article-title":"Prevention of ultraviolet-light-induced herpes labialis by sunscreen","volume":"338","author":"Rooney","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.tripleo.2006.11.004_bib68","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1079-2104(98)90398-5","article-title":"Oral acyclovir in prevention of herpes labialis","volume":"85","author":"Raborn","year":"1998","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"Suppl 1","key":"10.1016\/j.tripleo.2006.11.004_bib69","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1086\/343738","article-title":"Valacyclovir in the treatment of facial herpes simplex virus infection","volume":"186","author":"Laiskonis","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tripleo.2006.11.004_bib70","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1046\/j.1365-2133.2003.05062.x","article-title":"Valaciclovir as a single dose during prodrome of herpes facialis: a pilot randomized double-blind clinical trial","volume":"148","author":"Chosidow","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.tripleo.2006.11.004_bib71","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1128\/AAC.47.3.1072-1080.2003","article-title":"High-dose, short-duration, early valacyclovir therapy for episodic treatment of cold sores: results of two randomized, placebo-controlled, multicenter studies","volume":"47","author":"Spruance","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tripleo.2006.11.004_bib72","first-page":"239","article-title":"Valacyclovir for prevention of recurrent herpes labialis: 2 double-blind, placebo-controlled studies","volume":"71","author":"Baker","year":"2003","journal-title":"Cutis"},{"key":"10.1016\/j.tripleo.2006.11.004_bib73","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.14219\/jada.archive.2004.0407","article-title":"The efficacy of valacyclovir in preventing recurrent herpes simplex virus infections associated with dental procedures","volume":"135","author":"Miller","year":"2004","journal-title":"J Am Dent Assoc"},{"issue":"Suppl 1","key":"10.1016\/j.tripleo.2006.11.004_bib74","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/jmv.1890410507","article-title":"Prophylactic chemotherapy with acyclovir for recurrent herpes simplex labialis","author":"Spruance","year":"1993","journal-title":"J Med Virol"},{"key":"10.1016\/j.tripleo.2006.11.004_bib75","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/0002-9343(82)90085-7","article-title":"Pharmacokinetics of orally administered acyclovir in patients with herpes progenitalis","volume":"73","author":"Van Dyke","year":"1982","journal-title":"Am J Med"},{"key":"10.1016\/j.tripleo.2006.11.004_bib76","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0166-3542(95)00038-N","article-title":"Susceptibility to herpes labialis following multiple experimental exposures to ultraviolet radiation","volume":"28","author":"Spruance","year":"1995","journal-title":"Antiviral Res"},{"key":"10.1016\/j.tripleo.2006.11.004_bib77","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(76)90220-8","article-title":"An alternative theory of herpes-simplex recurrence and a possible role for prostaglandins","volume":"1","author":"Hill","year":"1976","journal-title":"Lancet"},{"key":"10.1016\/j.tripleo.2006.11.004_bib78","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1128\/AAC.39.12.2759","article-title":"Absolute bioavailability and metabolic disposition of valaciclovir, the L-valyl ester of acyclovir, following oral administration to humans","volume":"39","author":"Soul-Lawton","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tripleo.2006.11.004_bib79","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/clpt.1993.196","article-title":"Pharmacokinetics of the acyclovir pro-drug valaciclovir after escalating single- and multiple-dose administration to normal volunteers","volume":"54","author":"Weller","year":"1993","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.tripleo.2006.11.004_bib80","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/0030-4220(84)90031-8","article-title":"Pathogenesis of recurrent herpes simplex labialis","volume":"58","author":"Spruance","year":"1984","journal-title":"Oral Surg Oral Med Oral Pathol"},{"issue":"Suppl 1","key":"10.1016\/j.tripleo.2006.11.004_bib81","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1086\/342966","article-title":"Valacyclovir for herpes simplex virus infection: long-term safety and sustained efficacy after 20 years\u2019 experience with acyclovir","volume":"186","author":"Tyring","year":"2002","journal-title":"J Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.tripleo.2006.11.004_bib82","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/095632029300401S01","article-title":"Penciclovir: a review of the spectrum of activity, selectivity and cross resistance pattern","volume":"4","author":"Boyd","year":"1993","journal-title":"Antiviral Chem Chemother"},{"key":"10.1016\/j.tripleo.2006.11.004_bib83","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1128\/CMR.16.1.114-128.2003","article-title":"Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapy","volume":"16","author":"Bacon","year":"2003","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.tripleo.2006.11.004_bib84","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1001\/jama.277.17.1374","article-title":"Penciclovir cream for the treatment of herpes simplex labialis","volume":"277","author":"Spruance","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.tripleo.2006.11.004_bib85","doi-asserted-by":"crossref","first-page":"303","DOI":"10.14219\/jada.archive.2002.0169","article-title":"Effective treatment of herpes simplex labialis with penciclovir cream: combined results of two trials","volume":"133","author":"Raborn","year":"2002","journal-title":"J Am Dent Assoc"},{"key":"10.1016\/j.tripleo.2006.11.004_bib86","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0149-2918(00)87979-5","article-title":"Penciclovir cream for the treatment of sunlight-induced herpes simplex labialis: a randomized, double-blind, placebo-controlled trial","volume":"22","author":"Boon","year":"2000","journal-title":"Clin Ther"},{"key":"10.1016\/j.tripleo.2006.11.004_bib87","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1086\/322007","article-title":"Application of a topical immune response modifier, resiquimod gel, to modify the recurrence rate of recurrent genital herpes: a pilot study","volume":"184","author":"Spruance","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tripleo.2006.11.004_bib88","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1086\/315528","article-title":"Combination treatment with famciclovir and a topical corticosteroid gel versus famciclovir alone for experimental ultraviolet radiation-induced herpes simplex labialis: a pilot study","volume":"181","author":"Spruance","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tripleo.2006.11.004_bib89","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/095466302317584412","article-title":"Topical application of penciclovir cream for the treatment of herpes simplex facialis\/labialis: a randomized, double-blind, multicentre, aciclovir-controlled trial","volume":"13","author":"Lin","year":"2002","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.tripleo.2006.11.004_bib90","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1034\/j.1601-0825.2001.70107.x","article-title":"Recurrent herpes labialis: efficacy of topical therapy with penciclovir compared with acyclovir (aciclovir)","volume":"7","author":"Femiano","year":"2001","journal-title":"Oral Dis"},{"key":"10.1016\/j.tripleo.2006.11.004_bib91","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1086\/314605","article-title":"Peroral famciclovir in the treatment of experimental ultraviolet radiation-induced herpes simplex labialis: a double-blind, dose-ranging, placebo-controlled, multicenter trial","volume":"179","author":"Spruance","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tripleo.2006.11.004_bib92","doi-asserted-by":"crossref","first-page":"10825","DOI":"10.1073\/pnas.88.23.10825","article-title":"Antiviral activity of 1-docosanol, an inhibitor of lipid-enveloped viruses including herpes simplex","volume":"88","author":"Katz","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.tripleo.2006.11.004_bib93","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0166-3542(98)00048-5","article-title":"The anti-herpes simplex virus activity of n-docosanol includes inhibition of the viral entry process","volume":"40","author":"Pope","year":"1998","journal-title":"Antiviral Res"},{"key":"10.1016\/j.tripleo.2006.11.004_bib94","doi-asserted-by":"crossref","first-page":"479","DOI":"10.2340\/0001555576479481","article-title":"n-Docosanol 10% cream in the treatment of recurrent herpes labialis: a randomised, double-blind, placebo-controlled study","volume":"76","author":"Habbema","year":"1996","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.tripleo.2006.11.004_bib95","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1067\/mjd.2001.116215","article-title":"Clinical efficacy of topical docosanol 10% cream for herpes simplex labialis: a multicenter, randomized, placebo-controlled trial","volume":"45","author":"Sacks","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.tripleo.2006.11.004_bib96","first-page":"329","article-title":"Efficacy and safety of foscarnet for recurrent orolabial herpes: a multicentre randomized double-blind study","volume":"138","author":"Lawee","year":"1988","journal-title":"CMAJ"},{"key":"10.1016\/j.tripleo.2006.11.004_bib97","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1128\/AAC.41.9.1961","article-title":"Effect of foscarnet cream on experimental UV radiation-induced herpes labialis","volume":"41","author":"Bernstein","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tripleo.2006.11.004_bib98","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1365-2133.1995.tb05024.x","article-title":"A double-blind, placebo-controlled trial of continuous acyclovir therapy in recurrent erythema multiforme","volume":"132","author":"Tatnall","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.tripleo.2006.11.004_bib99","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1001\/archderm.134.7.876","article-title":"Recurrent erythema multiforme unresponsive to acyclovir prophylaxis and responsive to valacyclovir continuous therapy","volume":"134","author":"Kerob","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.tripleo.2006.11.004_bib100","doi-asserted-by":"crossref","first-page":"483","DOI":"10.14219\/jada.archive.1987.0120","article-title":"Oral herpes simplex infections in patients with leukemia","volume":"114","author":"Greenberg","year":"1987","journal-title":"J Am Dent Assoc"},{"key":"10.1016\/j.tripleo.2006.11.004_bib101","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/0030-4220(90)90142-F","article-title":"Oral and pharyngeal herpes simplex virus infection after allogeneic bone marrow transplantation: analysis of factors associated with infection","volume":"70","author":"Schubert","year":"1990","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1016\/j.tripleo.2006.11.004_bib102","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1079-2104(97)90011-1","article-title":"Oral recrudescent herpes simplex virus infection","volume":"83","author":"Woo","year":"1997","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.tripleo.2006.11.004_bib103","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/BF01963835","article-title":"Herpes simplex virus and intraoral ulcers in immunocompromised patients with haematologic malignancies","volume":"9","author":"Bergmann","year":"1990","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.tripleo.2006.11.004_bib104","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/0030-4220(86)90368-3","article-title":"The incidence of oral herpes simplex virus infection in patients undergoing cancer chemotherapy","volume":"61","author":"Montgomery","year":"1986","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1016\/j.tripleo.2006.11.004_bib105","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/infdis\/142.3.338","article-title":"Infection with herpes simplex virus and cell-mediated immunity after marrow transplant","volume":"142","author":"Meyers","year":"1980","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tripleo.2006.11.004_bib106","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/clinids\/18.3.401","article-title":"Herpes simplex viremia: report of eight pediatric cases and review of the literature","volume":"18","author":"Stanberry","year":"1994","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tripleo.2006.11.004_bib107","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/infdis\/150.3.323","article-title":"Infections caused by herpes simplex virus in the immunocompromised host: natural history and topical acyclovir therapy","volume":"150","author":"Whitley","year":"1984","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tripleo.2006.11.004_bib108","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0002-9343(82)90097-3","article-title":"Multicenter collaborative trial of intravenous acyclovir for treatment of mucocutaneous herpes simplex virus infection in the immunocompromised host","volume":"73","author":"Meyers","year":"1982","journal-title":"Am J Med"},{"key":"10.1016\/j.tripleo.2006.11.004_bib109","doi-asserted-by":"crossref","first-page":"783","DOI":"10.7326\/0003-4819-102-6-783","article-title":"Oral acyclovir therapy for mucocutaneous herpes simplex virus infections in immunocompromised marrow transplant recipients","volume":"102","author":"Shepp","year":"1985","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.tripleo.2006.11.004_bib110","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0140-6736(81)92569-1","article-title":"Acyclovir therapy for mucocutaneous herpes simplex infections in immunocompromised patients","volume":"1","author":"Mitchell","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.tripleo.2006.11.004_bib111","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1056\/NEJM198107093050202","article-title":"Acyclovir prophylaxis of herpes-simplex-virus infections","volume":"305","author":"Saral","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tripleo.2006.11.004_bib112","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1136\/bmj.287.6389.384","article-title":"Acyclovir prophylaxis against herpes virus infections in severely immunocompromised patients: randomised double blind trial","volume":"287","author":"Hann","year":"1983","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.tripleo.2006.11.004_bib113","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/S0140-6736(83)92248-1","article-title":"Prophylaxis of herpes infections after bone-marrow transplantation by oral acyclovir","volume":"2","author":"Gluckman","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.tripleo.2006.11.004_bib114","doi-asserted-by":"crossref","first-page":"823","DOI":"10.7326\/0003-4819-100-6-823","article-title":"Oral acyclovir for prevention of herpes simplex virus reactivation after marrow transplantation","volume":"100","author":"Wade","year":"1984","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.tripleo.2006.11.004_bib115","doi-asserted-by":"crossref","first-page":"773","DOI":"10.7326\/0003-4819-99-6-773","article-title":"Acyclovir prophylaxis against herpes simplex virus infection in patients with leukemia","volume":"99","author":"Saral","year":"1983","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.tripleo.2006.11.004_bib116","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1053\/bbmt.2002.v8.abbmt080662","article-title":"Oral valacyclovir versus intravenous acyclovir in preventing herpes simplex virus infections in autologous stem cell transplant recipients","volume":"8","author":"Liesveld","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.tripleo.2006.11.004_bib117","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/sj.bmt.1703354","article-title":"Valacyclovir prophylaxis for the prevention of Herpes simplex virus reactivation in recipients of progenitor cells transplantation","volume":"29","author":"Dignani","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.tripleo.2006.11.004_bib118","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/sj.bmt.1703817","article-title":"Clinical utility of oral valacyclovir compared with oral acyclovir for the prevention of herpes simplex virus mucositis following autologous bone marrow transplantation or stem cell rescue therapy","volume":"31","author":"Eisen","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.tripleo.2006.11.004_bib119","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1080\/10428190410001733763","article-title":"Oral valacyclovir as prophylaxis against herpes simplex virus reactivation during high dose chemotherapy for leukemia","volume":"45","author":"Orlowski","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.tripleo.2006.11.004_bib120","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1128\/AAC.43.5.1192","article-title":"Intravenous penciclovir for treatment of herpes simplex infections in immunocompromised patients: results of a multicenter, acyclovir-controlled trial","volume":"43","author":"Lazarus","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tripleo.2006.11.004_bib121","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/0030-4220(90)90239-O","article-title":"Oral herpes simplex virus infection in patients receiving head and neck radiation","volume":"69","author":"Redding","year":"1990","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1016\/j.tripleo.2006.11.004_bib122","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S1079-2104(97)90342-5","article-title":"Reactivation of oral herpes simplex virus: implications for clinical management of herpes simplex virus recurrence during radiotherapy","volume":"84","author":"Oakley","year":"1997","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.tripleo.2006.11.004_bib123","doi-asserted-by":"crossref","first-page":"21","DOI":"10.7326\/0003-4819-128-1-199801010-00004","article-title":"Famciclovir for the suppression of symptomatic and asymptomatic herpes simplex virus reactivation in HIV-infected persons","volume":"128","author":"Schacker","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.tripleo.2006.11.004_bib124","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1086\/513804","article-title":"A randomized, double-blind trial of valaciclovir prophylaxis for cytomegalovirus disease in patients with advanced human immunodeficiency virus infection","volume":"177","author":"Feinberg","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tripleo.2006.11.004_bib125","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1086\/321805","article-title":"Summary of the Guidelines for Preventing Opportunistic Infections among Hematopoietic Stem Cell Transplant Recipients","volume":"33","author":"Dykewicz","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tripleo.2006.11.004_bib126","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1086\/515626","article-title":"Phenotypic and genotypic characterization of acyclovir-resistant herpes simplex viruses from immunocompromised patients","volume":"178","author":"Gaudreau","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tripleo.2006.11.004_bib127","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1386-6532(02)00263-9","article-title":"Herpes simplex virus resistance to antiviral drugs","volume":"26","author":"Morfin","year":"2003","journal-title":"J Clin Virol"},{"key":"10.1016\/j.tripleo.2006.11.004_bib128","doi-asserted-by":"crossref","first-page":"416","DOI":"10.7326\/0003-4819-76-3-112-6-416","article-title":"Herpes simplex virus resistant to acyclovir","volume":"112","author":"Englund","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.tripleo.2006.11.004_bib129","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1128\/JCM.42.1.242-249.2004","article-title":"Surveillance network for herpes simplex virus resistance to antiviral drugs: 3-year follow-up","volume":"42","author":"Danve-Szatanek","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.tripleo.2006.11.004_bib130","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1007\/s00705-003-0124-7","article-title":"Profiling penciclovir susceptibility and prevalence of resistance of herpes simplex virus isolates across eleven clinical trials","volume":"148","author":"Sarisky","year":"2003","journal-title":"Arch Virol"},{"key":"10.1016\/j.tripleo.2006.11.004_bib131","first-page":"813","article-title":"European survey of herpesvirus resistance to antiviral drugs in bone marrow transplant recipients","volume":"17","author":"Reusser","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.tripleo.2006.11.004_bib132","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1086\/314052","article-title":"Resistant herpes simplex virus type 1 infection: an emerging concern after allogeneic stem cell transplantation","volume":"31","author":"Chen","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tripleo.2006.11.004_bib133","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1086\/516542","article-title":"A randomized, double-blind, placebo-controlled trial of cidofovir gel for the treatment of acyclovir-unresponsive mucocutaneous herpes simplex virus infection in patients with AIDS","volume":"176","author":"Lalezari","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tripleo.2006.11.004_bib134","doi-asserted-by":"crossref","first-page":"3724","DOI":"10.1128\/AAC.49.9.3724-3733.2005","article-title":"Comparative activities of lipid esters of cidofovir and cyclic cidofovir against replication of herpesviruses in vitro","volume":"49","author":"Williams-Aziz","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tripleo.2006.11.004_bib135","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1001\/archderm.134.9.1169","article-title":"Treatment of acyclovir-resistant, foscarnet-unresponsive HSV infection with topical cidofovir in a child with AIDS","volume":"134","author":"Lateef","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.tripleo.2006.11.004_bib136","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1093\/clinids\/18.4.570","article-title":"Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC)","volume":"18","author":"Snoeck","year":"1994","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tripleo.2006.11.004_bib137","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1097\/00006454-200111000-00016","article-title":"Successful treatment of foscarnet-resistant herpes simplex stomatitis with intravenous cidofovir in a child","volume":"20","author":"Bryant","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.tripleo.2006.11.004_bib138","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1086\/432802","article-title":"Evaluation of imiquimod 5% cream to modify the natural history of herpes labialis: a pilot study","volume":"41","author":"Bernstein","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tripleo.2006.11.004_bib139","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1046\/j.1365-2133.2002.504412.x","article-title":"Chronic erosive herpes simplex virus infection of the penis in a human immunodeficiency virus-positive man, treated with imiquimod and famciclovir","volume":"147","author":"Danielsen","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.tripleo.2006.11.004_bib140","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1086\/429240","article-title":"Safety and immunogenicity of glycoprotein D-adjuvant genital herpes vaccine","volume":"40","author":"Bernstein","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tripleo.2006.11.004_bib141","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/infdis\/161.2.191","article-title":"Early application of topical 15% idoxuridine in dimethyl sulfoxide shortens the course of herpes simplex labialis: a multicenter placebo-controlled trial","volume":"161","author":"Spruance","year":"1990","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tripleo.2006.11.004_bib142","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1086\/514042","article-title":"Topical undecylenic acid for herpes simplex labialis: a multicenter, placebo-controlled trial","volume":"176","author":"Shafran","year":"1997","journal-title":"J Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.tripleo.2006.11.004_bib143","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF02919055","article-title":"Prevention of recurrences in frequently relapsing herpes labialis with thymopentin","volume":"4","author":"Bolla","year":"1985","journal-title":"Surv Immunol Res"},{"key":"10.1016\/j.tripleo.2006.11.004_bib144","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/jac\/39.2.119","article-title":"New therapeutic approaches to the alphaherpesvirus infections","volume":"39","author":"Cassady","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.tripleo.2006.11.004_bib145","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/0030-4220(91)90160-E","article-title":"Determining therapeutic efficacy in recurrent herpes labialis by lesion size analysis","volume":"72","author":"Rodu","year":"1991","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1016\/j.tripleo.2006.11.004_bib146","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/S0190-9622(99)70260-4","article-title":"A double-blind, placebo-controlled study of topical tetracaine in the treatment of herpes labialis","volume":"41","author":"Kaminester","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.tripleo.2006.11.004_bib147","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0944-7113(99)80013-0","article-title":"Balm mint extract (Lo-701) for topical treatment of recurring herpes labialis","volume":"6","author":"Koytchev","year":"1999","journal-title":"Phytomedicine"},{"key":"10.1016\/j.tripleo.2006.11.004_bib148","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1034\/j.1601-0825.2001.70404.x","article-title":"LongoVital and herpes labialis: a randomised, double-blind, placebo-controlled study","volume":"7","author":"Pedersen","year":"2001","journal-title":"Oral Dis"},{"key":"10.1016\/j.tripleo.2006.11.004_bib149","first-page":"923","article-title":"Anti-herpes simplex virus effect of an aqueous extract of propolis","volume":"4","author":"Huleihel","year":"2002","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.tripleo.2006.11.004_bib150","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/AAC.25.1.10","article-title":"Penetration of guinea pig skin by acyclovir in different vehicles and correlation with the efficacy of topical therapy of experimental cutaneous herpes simplex virus infection","volume":"25","author":"Spruance","year":"1984","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079210406008638?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079210406008638?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T08:24:32Z","timestamp":1707726272000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079210406008638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":150,"alternative-id":["S1079210406008638"],"URL":"https:\/\/doi.org\/10.1016\/j.tripleo.2006.11.004","relation":{},"ISSN":["1079-2104"],"issn-type":[{"value":"1079-2104","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}